These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16682709)

  • 21. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.
    Ferguson JJ; Califf RM; Antman EM; Cohen M; Grines CL; Goodman S; Kereiakes DJ; Langer A; Mahaffey KW; Nessel CC; Armstrong PW; Avezum A; Aylward P; Becker RC; Biasucci L; Borzak S; Col J; Frey MJ; Fry E; Gulba DC; Guneri S; Gurfinkel E; Harrington R; Hochman JS; Kleiman NS; Leon MB; Lopez-Sendon JL; Pepine CJ; Ruzyllo W; Steinhubl SR; Teirstein PS; Toro-Figueroa L; White H;
    JAMA; 2004 Jul; 292(1):45-54. PubMed ID: 15238590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies.
    Spinler SA; Inverso SM; Cohen M; Goodman SG; Stringer KA; Antman EM;
    Am Heart J; 2003 Jul; 146(1):33-41. PubMed ID: 12851605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.
    Cohen M; Demers C; Gurfinkel EP; Turpie AG; Fromell GJ; Goodman S; Langer A; Califf RM; Fox KA; Premmereur J; Bigonzi F
    N Engl J Med; 1997 Aug; 337(7):447-52. PubMed ID: 9250846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial.
    Antman EM; Louwerenburg HW; Baars HF; Wesdorp JC; Hamer B; Bassand JP; Bigonzi F; Pisapia G; Gibson CM; Heidbuchel H; Braunwald E; Van de Werf F
    Circulation; 2002 Apr; 105(14):1642-9. PubMed ID: 11940541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview.
    Petersen JL; Mahaffey KW; Hasselblad V; Antman EM; Cohen M; Goodman SG; Langer A; Blazing MA; Le-Moigne-Amrani A; de Lemos JA; Nessel CC; Harrington RA; Ferguson JJ; Braunwald E; Califf RM
    JAMA; 2004 Jul; 292(1):89-96. PubMed ID: 15238596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin.
    Cohen M; Théroux P; Borzak S; Frey MJ; White HD; Van Mieghem W; Senatore F; Lis J; Mukherjee R; Harris K; Bigonzi F;
    Am Heart J; 2002 Sep; 144(3):470-7. PubMed ID: 12228784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials.
    De Luca G; Marino P
    Am Heart J; 2007 Dec; 154(6):1085.e1-6. PubMed ID: 18035079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial.
    Morrow DA; Antman EM; Murphy SA; Qin J; Ruda M; Guneri S; Jacob AJ; Budaj A; Braunwald E;
    Am Heart J; 2007 Dec; 154(6):1078-84, 1084.e1. PubMed ID: 18035078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-molecular-weight heparins as adjunctive therapy to thrombolytics: extracting the best data.
    Bailey AL; Steinhubl SR
    CMAJ; 2006 May; 174(10):1431-2. PubMed ID: 16682711
    [No Abstract]   [Full Text] [Related]  

  • 30. Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction.
    Baird SH; Menown IB; Mcbride SJ; Trouton TG; Wilson C
    Eur Heart J; 2002 Apr; 23(8):627-32. PubMed ID: 11969277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. International differences in in-hospital revascularization and outcomes following acute myocardial infarction: a multilevel analysis of patients in ASSENT-2.
    Gupta M; Chang WC; Van de Werf F; Granger CB; Midodzi W; Barbash G; Pehrson K; Oto A; Toutouzas P; Jansky P; Armstrong PW;
    Eur Heart J; 2003 Sep; 24(18):1640-50. PubMed ID: 14499226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tenecteplase: new preparation. Another thrombolytic agent for myocardial infarction: a slightly simpler treatment.
    Prescrire Int; 2002 Jun; 11(59):83-4. PubMed ID: 12068843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Facilitated percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: results from the prematurely terminated ADdressing the Value of facilitated ANgioplasty after Combination therapy or Eptifibatide monotherapy in acute Myocardial Infarction (ADVANCE MI) trial.
    ADVANCE MI Investigators
    Am Heart J; 2005 Jul; 150(1):116-22. PubMed ID: 16084157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25).
    Antman EM; Morrow DA; McCabe CH; Jiang F; White HD; Fox KA; Sharma D; Chew P; Braunwald E;
    Am Heart J; 2005 Feb; 149(2):217-26. PubMed ID: 15846258
    [No Abstract]   [Full Text] [Related]  

  • 35. Intravenous Enoxaparin Versus Unfractionated Heparin in Elderly Patients Undergoing Primary Percutaneous Coronary Intervention: An Analysis of the Randomized ATOLL Trial.
    Liu Z; Silvain J; Kerneis M; Barthélémy O; Payot L; Choussat R; Sabouret P; Cohen M; Pollack CV; Goldstein P; Zeymer U; Huber K; Vicaut E; Collet JP; Montalescot G
    Angiology; 2017 Jan; 68(1):29-39. PubMed ID: 26861858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of enoxaparin in combination with and without GP IIb/IIIa inhibitors in unselected patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Zeymer U; Gitt A; Zahn R; Jünger C; Bauer T; Heer T; Koeth O; Senges J
    EuroIntervention; 2009 Jan; 4(4):524-8. PubMed ID: 19284076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-molecular-weight heparins in conjunction with thrombolysis for ST-elevation acute myocardial infarction. A critical review of the literature.
    Rubboli A; Ottani F; Capecchi A; Brancaleoni R; Galvani M; Swahn E
    Cardiology; 2007; 107(2):132-9. PubMed ID: 16864962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Tenecteplase--the best among the equals.".
    Saran RK; Sethi R; Nagori M
    Indian Heart J; 2009; 61(5):454-8. PubMed ID: 20635761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy with tirofiban and enoxaparin in acute coronary syndromes.
    Cohen M; Théroux P; Weber S; Laramée P; Huynh T; Borzak S; Diodati JG; Squire IB; Deckelbaum LI; Thornton AR; Harris KE; Sax FL; Lo MW; White HD
    Int J Cardiol; 1999 Dec; 71(3):273-81. PubMed ID: 10636535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes and optimal antithrombotic therapy in women undergoing fibrinolysis for ST-elevation myocardial infarction.
    Mega JL; Morrow DA; Ostör E; Dorobantu M; Qin J; Antman EM; Braunwald E
    Circulation; 2007 Jun; 115(22):2822-8. PubMed ID: 17515461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.